Replies to post #11983 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

…[Teva’s] patents are very specific and would certainly provide a roadmap to a skilled company like Sandoz or Momenta should they deliberately choose to make a copy…

A roadmap, yes; however, your argument implies that Teva has no consequential trade secrets with respect to Copaxone, which I find hard to believe.